EFFECT OF ERYTHROPOIETIN ON RENAL EXCRETION OF A SODIUM LOAD

被引:7
作者
BUNKE, M [1 ]
GLEASON, JR [1 ]
BRIER, M [1 ]
SLOAN, R [1 ]
机构
[1] UNIV LOUISVILLE,DEPT MED,DIV NEPHROL,LOUISVILLE,KY 40292
关键词
D O I
10.1038/clpt.1994.70
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
To determine whether erythropoietin alters the renal excretion of a sodium load in humans, we administered either erythropoietin (150 units/kg) or vehicle intravenously in a randomized crossover design to six normal white men on day 4 of a controlled sodium diet. After erythropoietin administration, the subjects were given 2 L normal saline solution intravenously over 4 hours. All urine was collected for 4 days after drug administration. Serum sodium and creatinine levels and blood pressure were determined 0, 4, 8, and 24 hours after drug administration. Peripheral renin activity and aldosterone levels were determined 0, 4, and 8 hours after drug administration. Erythropoietin significantly decreased total sodium excretion during the 4 days after drug administration (erythropoietin = 784 +/- 46 mEq/4 days versus control = 840 +/- 41 mEq/4 days; p < 0.001). Erythropoietin did not alter creatinine clearance, blood pressure, or the changes in plasma renin activity and aldosterone caused by the saline load. We conclude that erythropoietin decreases urine sodium excretion after a sodium load in normal human subjects without altering glomerular filtration rate, blood pressure, or plasma renin activity.
引用
收藏
页码:563 / 568
页数:6
相关论文
共 29 条
[11]   DIRECT VASOPRESSOR EFFECT OF RECOMBINANT-HUMAN-ERYTHROPOIETIN ON RENAL RESISTANCE VESSELS [J].
HEIDENREICH, S ;
RAHN, KH ;
ZIDEK, W .
KIDNEY INTERNATIONAL, 1991, 39 (02) :259-265
[12]   THE GROWTH-HORMONE BINDING-PROTEIN AS A PARADIGM OF THE ERYTHROPOIETIN SUPERFAMILY OF RECEPTORS [J].
HOCHBERG, Z ;
AMIT, T ;
YOUDIM, MBH .
CELLULAR SIGNALLING, 1991, 3 (02) :85-91
[13]  
HORI K, 1990, CLIN NEPHROL, V33, P292
[14]   THE USE OF RECOMBINANT HUMAN ERYTHROPOIETIN IN THE CORRECTION OF ANEMIA IN PREDIALYSIS PATIENTS AND ITS EFFECT ON RENAL-FUNCTION - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].
KLEINMAN, KS ;
SCHWEITZER, SU ;
PERDUE, ST ;
BLEIFER, KH ;
ABELS, RI .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1989, 14 (06) :486-495
[15]   SALT SENSITIVITY OF BLOOD-PRESSURE IN CHRONIC-RENAL-FAILURE - EVIDENCE FOR RENAL CONTROL OF BODY-FLUID DISTRIBUTION IN MAN [J].
KOOMANS, HA ;
ROOS, JC ;
BOER, P ;
GEYSKES, GG ;
MEES, EJD .
HYPERTENSION, 1982, 4 (02) :190-197
[16]   VASCULAR CHANGES IN HEMODIALYSIS-PATIENTS IN RESPONSE TO RECOMBINANT HUMAN ERYTHROPOIETIN [J].
LONDON, GM ;
ZINS, B ;
PANNIER, B ;
NARET, C ;
BERTHELOT, JM ;
JACQUOT, C ;
SAFAR, M ;
DRUEKE, TB .
KIDNEY INTERNATIONAL, 1989, 36 (05) :878-882
[17]   ERYTHROPOIETIN TREATMENT OF ANEMIA ASSOCIATED WITH MULTIPLE-MYELOMA [J].
LUDWIG, H ;
FRITZ, E ;
KOTZMANN, H ;
HOCKER, P ;
GISSLINGER, H ;
BARNAS, U .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (24) :1693-1699
[18]   CARDIOVASCULAR AND HUMORAL RESPONSES TO EXTREMES OF SODIUM-INTAKE IN NORMAL BLACK AND WHITE MEN [J].
LUFT, FC ;
RANKIN, LI ;
BLOCH, R ;
WEYMAN, AE ;
WILLIS, LR ;
MURRAY, RH ;
GRIM, CE ;
WEINBERGER, MH .
CIRCULATION, 1979, 60 (03) :697-706
[19]   LONG-TERM EFFECTS OF TREATMENT WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN ON HEMODYNAMICS AND TISSUE OXYGENATION IN PATIENTS WITH RENAL ANEMIA [J].
NONNASTDANIEL, B ;
DESCHODT, G ;
BRUNKHORST, R ;
CREUTZIG, A ;
BAHLMANN, J ;
SHALDON, S ;
KOCH, KM .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1990, 5 (06) :444-448
[20]   HEMODYNAMIC-EFFECT OF RECOMBINANT-HUMAN-ERYTHROPOIETIN ON HYPOTENSIVE HEMODIALYSIS-PATIENTS [J].
ONOYAMA, K ;
HORI, K ;
OSATO, S ;
FUJISHIMA, M .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1991, 6 (08) :562-565